Krystal Biotech, Inc. logo KRYS - Krystal Biotech, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 17
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $336.40 DETAILS
HIGH: $371.00
LOW: $300.00
MEDIAN: $327.00
CONSENSUS: $336.40
DOWNSIDE: 10.31%
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue 389.1 290.5 50.7 0 0 0 0 1.0 0 0
Cost of Revenue 28.8 20.1 3.1 0 0 1.9 1.0 0.1 0.0 0.0
Gross Profit 360.4 270.5 47.6 0 0 (1.9) (1.0) 0.9 (0.0) (0.0)
Operating Expenses
R&D Expenses 58.0 53.6 46.4 42.5 27.9 17.9 15.6 7.8 3.2 0.7
SG&A Expenses 146.7 113.7 98.4 77.7 40.4 13.2 6.5 4.2 1.6 0.4
Other Expenses (5.7) 37.5 12.5 25 0 0 0 0 0 0
Operating Expenses 199.1 204.8 157.3 145.2 68.3 31.1 22.1 11.9 4.8 1.1
Operating Income
Operating Income 161.3 65.7 (109.7) (145.2) (68.3) (33.0) (22.1) (11.9) (4.8) (1.1)
Interest Expense 0 0 0 0 1.5 0 0 1.0 3.1 0.0
Interest Income 28.2 29.7 22.6 5.2 0.2 0.8 3.0 0 0 0
Profitability
EBITDA 196.0 109.9 (91.3) (116.8) (66.2) (30.3) (18.1) (10.7) (4.6) (1.1)
EBIT 189.5 103.2 (97.2) (120.2) (68.1) (32.2) (19.1) (10.9) (4.7) (1.1)
Income Before Tax 189.5 95.4 12.9 (140.0) (69.6) (32.2) (19.1) (10.9) (7.9) (1.1)
Income Tax Expense (15.4) 6.2 2.0 0 0 0 0 (0.0) 0 0
Net Income 204.8 89.2 10.9 (140.0) (69.6) (32.2) (19.1) (10.9) (7.9) (1.1)
Per Share Data
EPS (Basic) 7.08 3.12 0.40 -5.49 -3.13 -1.71 -1.20 -0.97 -1.48 -0.27
EPS (Diluted) 6.84 3.00 0.39 -5.49 -3.13 -1.71 -1.20 -0.97 -1.48 -0.27
Shares Outstanding 28.9 28.6 27.2 25.5 22.2 18.8 15.9 11.2 5.4 4.3
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 496.3 344.9 358.3 161.9 341.2 268.3 187.5 103.7 49.6 1.9
Short-Term Investments 331.5 252.7 173.8 217.3 96.8 3.0 6.2 8.1 0 0
Net Receivables 127.4 104.7 42.0 0 0 0 0 0 0 0
Inventory 40.5 26.5 7.0 0 0 0 0 0 0 0
Other Current Assets 28.9 13.3 6.7 4.6 0 0 0 0 0 0
Total Current Assets 1,024.6 742.0 587.9 383.8 442.3 275.1 195.9 112.7 49.9 2.2
Non-Current Assets
Property, Plant & Equipment 158.0 161.4 168.2 169.7 119.6 34.2 11.2 3.0 0.2 0.0
Goodwill 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 128.1 152.1 62.0 4.6 64.4 0 0.5 0 0 0
Other Non-Current Assets 0.3 0.2 0.3 0.3 0.1 1.6 1.5 0.5 0 0
Total Non-Current Assets 309.2 313.8 230.4 174.7 184.0 35.8 13.1 3.5 0.2 0.0
Total Assets 1,333.8 1,055.8 818.4 558.5 626.3 310.8 209.0 116.1 50.1 2.2
Current Liabilities
Account Payables 3.2 5.0 1.8 4.0 8.4 2.1 1.0 0.9 0.2 0.0
Short-Term Debt 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 3.6 2.4 16.8 0.3 0.1 0.0 0.0 1.4 0.4 0
Total Current Liabilities 102.9 102.0 33.1 28.8 25.7 15.5 3.3 2.6 0.6 0.0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 1.8
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 3.7 1.4 0 0 0 0 0 0.3 0 0.0
Total Non-Current Liabilities 11.3 7.5 6.6 7.4 7.0 3.3 2.8 0.3 0 1.9
Total Liabilities 114.2 109.5 39.7 36.2 32.7 18.8 6.1 2.9 0.6 1.9
Stockholders' Equity
Common Stock 0 0 0 0 0 0 0 0 0 0
Retained Earnings 24.2 (180.7) (269.8) (280.8) (140.8) (71.2) (39.0) (20.0) (9.1) (1.1)
Accumulated Other Comprehensive Income 1.1 (0.2) 0.6 (0.7) (0.2) 0.0 0.0 0.0 (0.0) (0.0)
Total Stockholders' Equity 1,219.6 946.4 778.6 522.2 593.6 292.1 202.9 113.2 49.5 0.3
Total Liabilities & Equity 1,333.8 1,055.8 818.4 558.5 626.3 310.8 209.0 116.1 50.1 2.2
Debt Metrics
Total Debt 9.3 7.3 8.1 8.9 8.0 11.5 3.3 0 0 1.8
Net Debt (487.0) (337.6) (350.2) (153.0) (333.2) (256.7) (184.3) (103.7) (49.6) (0.1)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income 204.8 89.2 10.9 (140.0) (69.6) (32.2) (19.1) (10.9) (7.9) (1.1)
Depreciation & Amortization 6.6 6.7 5.0 4.1 2.8 1.9 0.7 0.1 0.0 0.0
Stock-Based Compensation 54.5 49.1 39.9 33.2 15.3 3.3 1.2 0.8 0.2 0.0
Change in Working Capital (36.4) (14.5) (37.9) 2.8 2.1 0.9 (1.7) 0.5 0.5 (0.2)
Other Non-Cash Items (5.8) (7.1) (106.8) (0.7) 1.5 0.0 0.1 1.0 3.3 0.0
Operating Cash Flow 200.9 123.4 (88.8) (100.6) (47.9) (26.1) (18.7) (9.4) (3.9) (1.3)
Investing Activities
Capital Expenditure (12.0) (4.2) (11.8) (53.0) (68.3) (14.8) (6.4) (2.2) (0.2) (0.0)
Acquisitions 0.4 0 0 0 0 0 0 0 0 0
Purchases of Investments (422.5) (457.7) (508.8) (318.8) (190.5) (3.2) (9.1) (8.1) 0 0
Sales/Maturities of Investments 375.6 298.5 503.2 257.7 32.0 6.9 10.5 0 0 0
Other Investing Activities 0 0 100 0 0 0 0 0 0 0
Investing Cash Flow (58.4) (163.4) 82.6 (114.1) (226.8) (11.2) (5.0) (10.3) (0.2) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 2.3 1.8
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (14.0) (5.4) (0.7) (0.6) (8.0) 0 0 0 0 0
Financing Cash Flow 8.7 27.0 202.8 35.3 347.7 118.0 107.5 73.8 51.8 3.2
Cash Position
Net Change in Cash 151.4 (13.5) 196.4 (179.3) 73.0 80.8 83.8 54.1 47.7 1.9
Cash at Beginning 344.9 358.3 161.9 341.2 268.3 187.5 103.7 49.6 1.9 0
Cash at End 496.3 344.9 358.3 161.9 341.2 268.3 187.5 103.7 49.6 1.9
Free Cash Flow 188.9 119.2 (100.6) (153.5) (116.3) (40.9) (25.1) (11.7) (4.1) (1.3)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Income Statement
Revenue 389.1 290.5 50.7 0 0 0 0 1.0 0 0
Gross Profit 360.4 270.5 47.6 0 0 (1.9) (1.0) 0.9 (0.0) (0.0)
Operating Income 161.3 65.7 (109.7) (145.2) (68.3) (33.0) (22.1) (11.9) (4.8) (1.1)
Net Income 204.8 89.2 10.9 (140.0) (69.6) (32.2) (19.1) (10.9) (7.9) (1.1)
EPS (Diluted) 6.84 3.00 0.39 -5.49 -3.13 -1.71 -1.20 -0.97 -1.48 -0.27
Balance Sheet
Cash & Equivalents 496.3 344.9 358.3 161.9 341.2 268.3 187.5 103.7 49.6 1.9
Total Assets 1,333.8 1,055.8 818.4 558.5 626.3 310.8 209.0 116.1 50.1 2.2
Total Debt 9.3 7.3 8.1 8.9 8.0 11.5 3.3 0 0 1.8
Stockholders' Equity 1,219.6 946.4 778.6 522.2 593.6 292.1 202.9 113.2 49.5 0.3
Cash Flow
Operating Cash Flow 200.9 123.4 (88.8) (100.6) (47.9) (26.1) (18.7) (9.4) (3.9) (1.3)
Capital Expenditure (12.0) (4.2) (11.8) (53.0) (68.3) (14.8) (6.4) (2.2) (0.2) (0.0)
Free Cash Flow 188.9 119.2 (100.6) (153.5) (116.3) (40.9) (25.1) (11.7) (4.1) (1.3)